SCHEMBL68232

SCHEMBL68232

OCc1ccc(O)c(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.67
CA2 P00918 1/20 0.67
CA4 P22748 1/20 0.67
CA6 P23280 1/20 0.67
KDM4E B2RXH2 6/20 0.65
MAPT P10636 6/20 0.65
ALDH1A1 P00352 4/20 0.65
GAA P10253 3/20 0.65
ALOX5 P09917 2/20 0.65
BACE1 P56817 1/20 0.65
ALOX15 P16050 6/20 0.61
IGF1R P08069 3/20 0.61
TRPA1 O75762 2/20 0.61
MAPK1 P28482 4/20 0.56
RECQL P46063 4/20 0.56
HIF1A Q16665 4/20 0.56
HSD17B10 Q99714 4/20 0.56
TDP1 Q9NUW8 4/20 0.56
TP53 P04637 3/20 0.56
DRD2 P14416 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29404315 1.00 CA1 (0.67) CA1CA2CA4CA6KDM4E
Malonic Acid SCHEMBL28777954 0.85 KDM4E (0.62) CA1CA2CA4CA6KDM4E
SCHEMBL30631592 0.80 ALOX15 (0.80) CA1CA2CA4CA6KDM4E
SCHEMBL108093 0.80 CA1 (1.00) CA1CA2CA4CA6KDM4E
SCHEMBL107956 0.80 ALOX15 (0.80) CA1CA2CA4CA6KDM4E
SCHEMBL11786007 0.79 TTR (0.47) CA1CA2CA4CA6KDM4E
Hydroxytyrosol SCHEMBL29414541 0.79 MAPT (1.00) CA1CA2CA4CA6KDM4E
Hydroxytyrosol SCHEMBL44363 0.79 MAPT (1.00) CA1CA2CA4CA6KDM4E
SCHEMBL29942487 0.79 PKM (0.55) CA1CA2CA4CA6KDM4E
SCHEMBL1604304 0.79 PKM (0.55) CA1CA2CA4CA6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 476 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250305012-A1 METHOD FOR PREPARING KETO ACIDS, AND USE OF SAME IN PREPARATION OF AMINO ACIDS OR AMINO ACID DERIVATIVES MINT BIOTECHNOLOGIES CO., LTD. (CN) 2025-10-02 US claimed
EP-4619472-A1 MODIFIED PRECIPITATED SILICA, ITS MANUFACTURE AND USE RHODIA OPERATIONS (FR) 2025-09-24 EP claimed
US-20250276107-A1 HYDROGEL SYSTEMS AND METHODS FOR TREATING FISTULA AND OTHER INDICATIONS TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION (US) 2025-09-04 US claimed
EP-4509610-A1 METHOD FOR PREPARING KETO ACIDS, AND USE OF SAME IN PREPARATION OF AMINO ACIDS OR AMINO ACID DERIVATIVES Mint Biotechnologies Co., Ltd. (CN) 2025-02-19 EP claimed
WO-2024104971-A1 MODIFIED PRECIPITATED SILICA, ITS MANUFACTURE AND USE RHODIA OPERATIONS (FR) 2024-05-23 WO claimed
EP-4076841-B1 BONDED ABRASIVE ARTICLE AND METHOD OF MAKING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-01-31 EP claimed
WO-2023198017-A1 METHOD FOR PREPARING KETO ACIDS, AND USE OF SAME IN PREPARATION OF AMINO ACIDS OR AMINO ACID DERIVATIVES 元素驱动(杭州)生物科技有限公司 2023-10-19 WO claimed
US-11718766-B2 Self-repairing polyurethane networks CLEMSON UNIVERSITY (US) 2023-08-08 US claimed
CN-116376989-A Method for preparing keto acid and application of method in preparation of amino acid or amino acid derivative 元素驱动(杭州)生物科技有限公司 2023-07-04 CN claimed
CN-115737483-A Emulsion gel, emulsion gel composite and preparation method thereof 杭州唯铂莱生物科技有限公司 2023-03-07 CN claimed
US-20030041391-A1 Agent and method for dyeing keratin fibres Wella GmbH (DE) 2003-03-06 US claimed
EP-1012235-A4 IMPROVED VANILLIN PRODUCTION DAVID MICHAEL & CO INC (US) 2002-07-31 EP claimed
WO-2002047633-A2 AGENT AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2002-06-20 WO claimed
WO-2001098235-A2 3,4-DIHYDROXYBENZYL-SUBSTITUTED CARBONIC ACID DERIVATIVES AND THE USE THEREOF AS ANTIOXIDANTS HAARMANN & REIMER GMBH (DE) 2001-12-27 WO claimed
EP-1012235-A1 IMPROVED VANILLIN PRODUCTION David Michael & CO., Inc. (US) 2000-06-28 EP claimed
JP-2000502332-A 2000-02-29 JP claimed
WO-1999003975-A1 IMPROVED VANILLIN PRODUCTION DAVID MICHAEL & CO., INC. (US) 1999-01-28 WO claimed
EP-0873519-A1 HIV PROTEASE INHIBITORS The Scripps Research Institute (US) 1998-10-28 EP claimed
WO-1997021100-A9 HIV PROTEASE INHIBITORS 1997-10-30 WO claimed
WO-1997021100-A1 HIV PROTEASE INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 1997-06-12 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030041391-A1 Agent and method for dyeing keratin fibres KRT18, AKR7A2, ADH5 CA1 1165/4885CA2 1930/4885CA4 699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.